| A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal |
119 |
| Molecular characterization of cancers with NTRK gene fusions |
80 |
| Implications of the tumor immune microenvironment for staging and therapeutics |
57 |
| Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine |
55 |
| Hepatotoxicity of immune checkpoint inhibitors: a histology study of seven cases in comparison with autoimmune hepatitis and idiosyncratic drug-induced liver injury |
40 |
| SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma |
27 |
| Using deep convolutional neural networks to identify and classify tumor-associated stroma in diagnostic breast biopsies |
25 |
| &ITZC3H7B-BCOR&IT high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity |
25 |
| Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy |
24 |
| Breast implant-associated anaplastic large cell lymphoma: a review |
23 |
| Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a review for pathologists |
22 |
| Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma |
20 |
| Concordance study of PD-L1 expression in primary and metastatic bladder carcinomas: comparison of four commonly used antibodies and RNA expression |
19 |
| Array-based DNA-methylation profiling in sarcomas with small blue round cell histology provides valuable diagnostic information |
18 |
| Whole slide imaging equivalency and efficiency study: experience at a large academic center |
18 |
| Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study |
18 |
| Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42 |
18 |
| Uterine and vaginal sarcomas resembling fibrosarcoma: a clinicopathological and molecular analysis of 13 cases showing common NTRK-rearrangements and the description of a COL1A1-PDGFB fusion novel to uterine neoplasms |
18 |
| Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis |
17 |
| Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices |
17 |
| Salvaging the supernatant: next generation cytopathology for solid tumor mutation profiling |
17 |
| MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification |
17 |
| Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections |
17 |
| DICER1 mutations are frequent in mullerian adenosarcomas and are independent of rhabdomyosarcomatous differentiation |
17 |
| Immunohistochemical detection of PD-L1 among diverse human neoplasms in a reference laboratory: observations based upon 896 cases |
17 |
| Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast |
16 |
| Genomic profiling of metaplastic breast carcinomas reveals genetic heterogeneity and relationship to ductal carcinoma |
16 |
| NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma |
16 |
| Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma |
16 |
| Nuclear beta-catenin localization and mutation of the CTNNB1 gene: a context-dependent association |
15 |
| Assessment of programmed cell death ligand-1 expression by 4 diagnostic assays and its clinicopathological correlation in a large cohort of surgical resected non-small cell lung carcinoma |
15 |
| Adenomatoid tumors of the male and female genital tract are defined by &ITTRAF7&IT mutations that drive aberrant NF-kB pathway activation |
15 |
| The histopathology of Erdheim-Chester disease: a comprehensive review of a molecularly characterized cohort |
15 |
| NUTM1-rearranged neoplasia: a multi-institution experience yields novel fusion partners and expands the histologic spectrum |
14 |
| An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer |
14 |
| Genomic heterogeneity of ALK fusion breakpoints in non-small-cell lung cancer |
14 |
| Epidemiology and biomarker profile of pituitary adenohypophysial tumors |
14 |
| Clinical, pathological, and genomic features of EWSR1-PATZ1 fusion sarcoma |
14 |
| SATB2 and CDX2 are prognostic biomarkers in DNA mismatch repair protein deficient colon cancer |
13 |
| SMARCA4 inactivation defines a subset of undifferentiated uterine sarcomas with rhabdoid and small cell features and germline mutation association |
13 |
| RNA sequencing of Xp11 translocation-associated cancers reveals novel gene fusions and distinctive clinicopathologic correlations |
13 |
| Pattern multiplicity and fumarate hydratase (FH)/S-(2-succino)-cysteine (2SC) staining but not eosinophilic nucleoli with perinucleolar halos differentiate hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinomas from kidney tumors without FH gene alteration |
13 |
| Diagnostic accuracy of a panel of immunohistochemical and molecular markers to distinguish Merkel cell carcinoma from other neuroendocrine carcinomas |
13 |
| JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management |
13 |
| Clinicopathologic characteristics of poorly differentiated chordoma |
13 |
| Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT/beta-catenin pathway |
12 |
| Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays |
12 |
| Combined mutation and copy-number variation detection by targeted next-generation sequencing in uveal melanoma |
12 |
| Prevalence of recurrent oncogenic fusion in mismatch repair-deficient colorectal carcinoma with hypermethylated MLH1 and wild-type BRAF and KRAS |
12 |
| Multiregion gene expression profiling reveals heterogeneity in molecular subtypes and immunotherapy response signatures in lung cancer |
12 |
